ACT Raises More Funding

From Mass High Tech, welcome news that Advanced Cell Technology has raised another $17 million in venture funding. "The proceeds of the financing are expected to be used by the company for general corporate purposes and to accelerate its research and development of human embryonic stem cell technology and stem cell therapies with particular emphasis on retinal, dermal and hemangioblast cell lines." ACT has been something of a bellwether for private funding of stem cell based regenerative medicine - this news indicates an upturn in the funding environment is well under way for this vital branch of medical science. Good news for those people looking towards a future of effective therapies for common age-related conditions.

Link: http://www.masshightech.com/displayarticledetail.asp?Art_ID=69677

Comments

Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.